EUROPEAN CONSENSUS TABLE ON THE USE OF BOTULINUM TOXIN TYPE A IN ADULT SPASTICITY

Date
2009
Author
Deltombe, Thierry
Wissel, Joerg
Ward, Anthony B.
Erztgaard, Per
Bensmail, Djamel
Hecht, Martin J.
Lejeune, Thierry M.
Schnider, Peter
Altavista, Maria C.
Cavazza, Stefano
Duarte, Esther
Geurts, Alexander C. H.
Gracies, Jean-Michel
Haboubi, Naseer H. J.
Juan, Francisco J.
Kasch, Helge
Kaetterer, Christian
KİRAZLI, YEŞİM
Manganotti, Paolo
Paternostro-Sluga, Tatjana
Petropoulou, Konstantina
Prempeh, Robert
Rousseaux, Marc
Slawek, Jaroslaw
Tieranta, Niko
Parman, Yesim
Metadata
Show full item record
Abstract
A group of clinicians from across Europe experienced in the use of botulinum toxin type a for the treatment of spasticity following acquired brain injury gathered to develop a consensus statement on best practice in managing adults with spasticity. this consensus table summarizes the current published data, which was collated following extensive literature searches, their assessment for level of evidence and discussion among the whole group. published information is supplemented by expert opinion based on clinical experience from 16 European countries, involving 28 clinicians, who treat an average of approximately 200 patients annually, representing many thousand spasticity treatments with botulinum toxin per year.
URI
http://hdl.handle.net/20.500.12627/43883
https://doi.org/10.2340/16501977-0303
Collections